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Abstract
Dopamine plays an important role in goal-directed behavior, through its modulatory influence on striatal neurons. It is
unclear whether tonic dopamine levels, which regulate the vigor of acting, interact with the phasic dopamine response to
reward that drives instrumental behavior. In a randomized placebo-controlled study in healthy volunteers, we show that
methylphenidate, a drug that increases tonic dopamine levels, systematically reduced striatal phasic BOLD responses to
gain and loss in a gambling task as measured with fMRI. It also increased response vigor and reward expectancy-related
BOLD signals in the ventral striatum. These findings suggest that striatal tonic dopamine levels constitute an average re-
ward expectation signal that modulates the phasic dopaminergic response to reward. This offers opportunities for treat-
ment of behavioral disorders associated with abnormal reward sensitivity.
Key words: dopamine; Pharmacological fMRI; feedback; gambling
Introduction
The basal ganglia and prefrontal cortex play a critical role in
voluntary behavior and reward-based learning. Both actions
are modulated by dopamine that is released by midbrain neu-
rons into the striatum. A range of studies show that tonic dopa-
mine in the striatum facilitates action initiation and
performance vigor. Drugs that increase tonic dopamine in the
striatum, such as cocaine and methylphenidate (MPH), increase
motor responsiveness and action readiness (Advokat, 2010;
Spronk et al., 2013). Low levels of striatal dopamine on the other
hand decrease response vigor and may cause loss of voluntary
movement as in Parkinson’s disease (Antonelli and Strafella,
2014).
Electrophysiological studies of reward-based learning have
shown that dopaminergic midbrain neurons also encode re-
ward prediction error (RPE): when an outcome is better than ex-
pected their firing temporarily rises above baseline (burst
firing), and when an outcome is worse than expected their firing
falls below baseline (Schultz, 2007). Burst firing leads to a tem-
porary increase in dopamine release (phasic dopamine) in dopa-
minergic projection regions such as the ventral striatum.
Niv (2007) suggested that the role of dopamine in voluntary
behavior and reward-based learning are not independent.
They hypothesized that tonic dopamine, besides controlling re-
sponse vigor, also represents an average reward expectancy sig-
nal reflecting past reward history. Frequent release of phasic
dopamine, following abundant rewards, leads to dopamine
spill-over and thereby increases tonic dopamine and action
readiness. In other words, a rich reward context promotes high
action utility. Similarly, sporadic reward would decrease tonic
dopamine, signaling a low action utility in a poor reward con-
text. Several studies confirmed that response vigor fluctuates as
a function of both reward history (Guitart-Masip et al., 2011) and
drug induced changes in tonic dopamine (Beierholm et al., 2013).
Cools et al. (2011) subsequently proposed that tonic dopa-
mine, as a signal of reward expectancy, would also interfere
with reward learning mechanisms governed by phasic dopa-
mine. The phasic dopamine response reflects the discrepancy
between expected and received reward, and a change in tonic
dopamine would alter the magnitude of this discrepancy. Low
reward expectancy and low tonic dopamine will allow for a
large phasic dopamine response to unexpected reward. In
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contrast, high reward expectancy and high levels of tonic dopa-
mine will only allow for a small phasic response to unexpected
reward. Understanding the relationship between tonic and pha-
sic dopamine would have important implications for predicting
dopaminergic drug effects in patients with abnormal reward
sensitivity.
Our aim was to obtain direct evidence of this relationship be-
tween tonic and phasic dopamine response in a pharmaco-
logical functional MRI (fMRI) study. Twenty healthy participants
entered a double blind study and performed a gambling task
(Camara et al., 2010; Gehring and Willoughby, 2010) during fMRI
scanning sessions after receiving a single dose of placebo and
MPH 40mg. Relative to previous studies (Knutson et al., 2004;
Pessiglione et al., 2006; Dodds et al., 2008), we introduced two
modifications to increase design sensitivity. First, previous
studies defined the reward-related BOLD response as the differ-
ence between the least and the most appealing reward condi-
tion, obscuring the parametric relation of the BOLD signal to the
RPE. Instead, we created a full-range parametric variation of the
RPE from unexpected high punishment to unexpected large re-
ward and measured the phasic dopamine response for each
level. Second, previous studies used task paradigms in which
participants learn to improve performance. Such tasks engage
other systems beyond the striatum that modulate striatal activ-
ity and are themselves modulated by dopaminergic manipula-
tions. In our gambling paradigm (Camara et al., 2010),
participants chose between two levels of reward amplitude on
each trial. Although this choice induced reward expectancy, at
feedback participants were passively subjected to arbitrary
gains or losses. Thus, before entering the scanner participants
had learned that their choice is arbitrary and had no implica-
tions for the outcome. As a consequence, phasic DA release
could be expected to reliably reflect the parametrically manipu-
lated feedback that we provided.
Based on the hypotheses described earlier and the task para-
digm used, we made the following predictions regarding the
striatal BOLD signal. First, rewards received in previous trials
were expected to increase tonic striatal DA levels and therefore
reward expectation signals in the current trial. This should be
most evident in the time window following choice, and we
tested this in statistical model 3 (cf. below). Second, the increase
of tonic DA after MPH administration was also expected to
heighten reward expectation, again leading to increased striatal
BOLD signal following choice. The prime effect of MPH on re-
ward expectation, independent of trial history related expect-
ation was tested in statistical model 4 (cf. below). Choice and
feedback related expectations were basically zero in this model
because participants were unable to learn choice dependent
outcome expectations and because BOLD signal estimates were
averaged over trials which nullified the impact of random re-
ward expectations from preceding trials. This approach there-
fore allowed independent assessments of trail induced (model
3) and drug induced changes (model 4) in tonic DA on reward
expectations. We predicted that MPH would decrease the stri-
atal phasic BOLD response to feedback, because of a higher
tonic dopamine and thus higher reward expectancy level in the
drug condition.
Materials and methods
Participants
Twenty-four healthy women and men (23–35 years) participated
in this study. Inclusion criteria: right handedness, no history of
mental illness or neurological disorders, no history of drug or al-
cohol abuse, and no use of medication. After inclusion, partici-
pants completed a thorough medical questionnaire and a full
physical was performed. Exclusion criteria: abnormal blood
pressure (more than 160/95mm Hg), or pulse rate, MRI contra-
indications, cardiovascular abnormalities as assessed by a
12-lead ECG, hematology and biochemistry values indicative of
illness or pregnancy, positive results on the drug screen, exces-
sive drinking (>20 alcohol consumptions a week), and contra-
indications to MPH.
FMRI results reported are based on data from twenty partici-
pants (10 men; mean age 23; SD ¼1.6). Data from three other
participants were excluded due to sleep, panic, and nervous-
ness during scanning. FMRI data of one other subject was
excluded because of large ventricles. Her behavioral data how-
ever was included for data analysis (21 behavioral datasets).
This study was approved by the local medical ethical com-
mittee and carried out in accordance with the declaration of
Helsinki (1991). Participants gave informed consent and were
compensated for participation.
Procedures
Participants were tested after administration of placebo and
MPH 40mg according to a randomized double-blind within-sub-
ject design (order 1, placebo first; order 2, MPH first; half of the
participants received order 1 and the other half order 2). When
participants arrived at the laboratory (T0), they completed the
Bond and Lader Questionnaire [(1); for description see section
‘Subjective Measures’ below], a blood sample was taken, and
the encapsulated MPH or placebo was administered. At the end
of a 1 h waiting period (T1), participants again completed the
questionnaire and a second blood sample was taken. The scan
session started on average 108 (SD ¼ 14) and ended on average
197 (SD ¼ 16) minutes after drug administration (calculated for
participants who’s fMRI data were analyzed). After scanning
(T2) participants again completed the questionnaire and a third
blood sample was taken.
Plasma values
Plasma MPH and ritalinic acid were determined with liquid
chromatography-mass spectrometry. A repeated-measures
ANOVA (RM-ANOVA) with Treatment (two levels) and Time
(three levels) as within-subject factors was carried out for
plasma MPH and ritalinic acid (SPSS, version 21).
Subjective measures
The Bond and Lader Questionnaire (Bond and Lader, 1974) con-
sists of 16 bipolar set of adjectives loading onto three subscales:
alertness, contentedness and calmness. A RM-ANOVA with
Treatment and Time as within-subject variables and Order (two
levels: placebo or MPH first) as covariate was carried out. To cor-
rect for multiple testing, effects were considered significant
when P < 0.01.
Gambling task
During fMRI scanning participants performed a gambling task
(see Figure 1 for details). To allow investigation of the paramet-
ric variation of BOLD signal change with the size and valence of
the RPE the following ordered sequence of event types was cre-
ated: Gain 125, Gain 7/27 (Gain 7 and 27 combined), Gain 25,
Gain 5, Loss 5, Loss 25, Loss 7/27, Loss 125. In addition, Choice 5,
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and Choice 25 events represented the response of participants
relative to the cue stimulus. In total, 600 forced choice and 60
dummy trials (fixation cross for 4 s) were randomly presented
across 5 runs (40min in total).
To increase motivation, two modifications to the Camara
et al. (2010) task were made: (i) at the bottom of the screen a bar
showed the total score (red for negative and green for positive),
(ii) at the top of the screen for each individual trial the points
lost or gained were presented.
Performance analysis
Response times. The average response time (RT) on the subse-
quent trial was calculated for each event type. Two participants
responded extremely slowly (average RT > 2 SDs above mean).
They were considered outliers and their data was excluded to
avoid violation of parametric assumptions.
A RM-ANOVA, with Treatment and Event Type (eight levels)
as within subject variables, and Order (two levels) as covariate,
was carried out. A Greenhouse-Geisser correction was applied
when appropriate.
Choice behavior. For each event trial, the percentage of subse-
quent trials on which ‘25’ was chosen was calculated. RM-
ANOVAs with Treatment and Event Types as within subject
variable and Order as covariate, was carried out.
Image acquisition
MRI images were acquired with a Siemens 3T head only scanner
(Magnetom Allegra, Siemens Medical Systems, Erlangen,
Germany). Whole brain EPI images: TR ¼ 2.0 s; TE ¼ 30ms; FOV
¼ 224  224mm; flip angle ¼ 90; interleaved slice acquisition;
32 oblique slices; 64  64 matrix; voxel size ¼ 3.5  3.5  3.5mm.
T1-weighted anatomical scan: TR ¼ 2.25 s; TE ¼ 2.6ms; flip angle
¼ 9, 256  256 matrix, 192 sagittal slices; voxel size ¼ 1  1 
1mm.
Analysis of the fMRI data
SPM8 (Wellcome Trust Centre for Neuroimaging, London, UK)
was used for preprocessing and analysis. Preprocessing steps: (i)
the first three volumes were deleted, (ii) slice-time correction,
(iii) within run realignment, (iv) for each session, volumes from
run 2 till 5 were coregistered to the volumes of run 1, (v) spatial
normalization of functional images (parameters estimated
without segmentation onto the MNI EPI template and images
resliced to 2  2  2mm) and (vi) 4mm smoothing.
The following events were modeled: Choice 5 (‘at choice
response onset’), Choice 25, Gain 125 (at feedback onset),
Gain 7/27 (Gain 7 and 27 combined), Gain 25, Gain 5, Loss 5,
Loss 25, Loss 7/27, Loss 125. Events were modeled with a
standard canonical HRF and no time and dispersion deriva-
tives were included. The time series were high pass filtered
(128 s).
For each individual, four GLMs were built to study the effects
of MPH on the BOLD response. In each GLM, 6 realignment par-
ameters (RPs) were added as regressors of no interest. The RPEs
used in model 1–3 were calculated with a Toolbox for
Estimating Parameters of Reinforcement Learning Models cre-
ated by Jee Hoon Yoo, University of Bristol, September 2008. The
indirect actor model was used, which uses a standard basic re-
inforcement learning model. Updating procedure: mi¼mjþ d
where d¼ rj – mj. In the equation, i indexes the current trial and j
the preceding trial. The variable mi is the action value of the
chosen alternative in the current trial.  denotes the learning
rate, and d represents the difference between received reward rj
and action value mj. in the previous trial. We also investigated
the effect of MPH on the negative likelihood (a measure of the
total model fit), the learning rate and the exploration
parameter.
In demonstrating RPE effects at the time of feedback, it has
become common practice to split up the RPE into the reward ex-
pectation, which negatively correlates with RPE effects, and the
actual reward received, which positively correlates with any
RPE effect (Rushworth and Behrens, 2008; Rutledge et al., 2014).
However, because in our random-feedback paradigm partici-
pant learn that the outcome is random, their stimulus-related
reward expectancy at the moment of feedback is constant and
RPE will co-vary with the amount of reward received. Hence, we
did not split up the RPE.
Model 1. RPE. Parameters: feedback (all feedback events;
modeled to feedback onset), RPE as parametric modulator,
which scales the amplitude of the hemodynamic response dur-
ing feedback, 6RPs.
Model 2. Absolute RPE. The absolute value of the PE is a
measure for the salience of feedback. Parameters: feedback, ab-
solute value of the RPE as parametric modulator and 6RPs
Model 3. RPE History. The receipt of a large reward raises the
expectancy to receive reward on the next trial. In other words,
the BOLD response in the ventral striatum (reward expectancy)
associated with choice, depends on the RPE received on the
Fig. 1. During fMRI scanning participants performed a gambling task with the intent to win as many points as possible. A fixation cross was presented for 0.5 s followed
by the numbers ‘5’ and ‘25’ (choice cue). The left/right position of these cues was randomized. Participants chose a number by pressing the corresponding button. One
second later, the boxes around the numbers turned both green (indicating gain) and both red (indicating loss) and stayed on the screen for 1.5 s. The intertrial interval
was 3 s plus RT. When participants chose ‘5’, they could gain or lose 5 (80% of trials, expected small gain or loss), 7 (10%, unexpected small gain or loss) or 125 points
(10%, unexpected large gain or loss); when they chose ‘25’, they could win or lose 25 (80%, expected small gain or loss), 27 (10%, unexpected small gain or loss), or 125
points (10%, unexpected large gain or loss). In the present example, the participant chose ‘5’, and gained 125 points. The color bar below indicated the total amount of
points collected so far.
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previous trial. Parameters: Choice (button press), RPE of the pre-
ceding trial as parametric modulator and 6RPs
Model 4. This model was used to plot the percent signal
changes for all modeled events for clusters were effects of MPH
were found. This model allowed assessing the influence of MPH
on reward expectation, independent of any reward history
related expectations. That is, gains and losses assigned after a
choice were completely arbitrary and as a consequence subjects
were not able to learn any systematic choice-outcome contin-
gencies. In addition, any random expectations to may have
occurred based on rewards received in preceding trials were
also neutralized by averaging BOLD signal estimates over trials
in each event type. Therefore, MPH changes in tonic DA was the
sole determinator of reward expectation in the feedback esti-
mates. These estimates were used to check for MPH effects on
the average BOLD response (contrast 1), and to examine the
task-related BOLD response to feedback in general (contrast 2).
Parameters: all event types separately, Fixation, Choice 5,
Choice 25 and 6RPs
For each model contrast images from the individual ana-
lysis were used as input for dependent t-tests, in which Order
was added as a covariate. Firstly, task-related effects were
examined within the placebo-condition using a whole brain
analysis. A second set of whole brain analyses investigated the
effects of MPH for the different models. For both analysis we
used PFWE-corrected at cluster level < 0.05 with an extend
threshold of > 5 voxels. MNI coordinates were labeled accord-
ing to the AAL regions (Tzourio-Mazoyer et al., 2002). We used
the CA-CP line as a pragmatic guideline to define the ventral
striatum. Striatal clusters with a negative z-value are con-
sidered ventral striatum (including ventral putamen and caud-
ate; in line with the ventral ROI used in e.g. Hiebert et al., 2014).
The SPM toolbox RFX-plot (Gl€ascher, 2009) was used to extract
percent signal changes.
A slope analysis was carried out to examine if MPH changes
the relationship between the parametric manipulations of RPEs
and the event-related BOLD response. For this analysis, the ana-
lysis event types were recoded as follows: Gain 125 to 4, Gain 7/
200
300
400
500
600
700
800
900
1000
gain 5 gain
25
gain
7/27
gain
125
loss 5 loss
25
loss
7/27
loss
125
gain 5 gain
25
gain
7/27
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125
loss 5 loss
25
loss
7/27
loss
125
Placebo Methylphenidate
Fig. 2. The average reaction time (in ms) on the next trial for the different gain and loss events, during placebo and MPH (with SDs).
Fig. 3. A shows the ventral striatal cluster for which the BOLD response is positively correlated with the RPE in the placebo condition (model 1), and B shows the ventral
striatal cluster for which the BOLD response correlates positively with the RPE history during placebo (model 3). Both clusters are shown at coronal slices at x¼ 15.
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27 to 3, Gain 25 to 2, Gain 5 to 1, Loss 5 to 1, Loss 25 to 2, Loss
7/27 to 3 and Loss 125 to -4.
Results
Effectiveness of psychopharmacological manipulation
Control measures showed that MPH manipulations were suc-
cessful. Statistical analysis of the plasma MPH concentrations (n
¼ 19) showed a main effect of Treatment [F(1,18) ¼ 33.8; P <
0.001] and Time [F(2,36) ¼ 15.0; P < 0.001], and an interaction be-
tween Treatment and Time [F(2,36) ¼ 15.0; P < 0.001]. For plasma
Ritalinic Acid concentrations (n ¼ 19), a main effect of
Treatment [F(1,18) ¼ 104.0; P < 0.001] and Time [F(2,36) ¼ 33.7; P
< 0.001], and an interaction between Treatment and Time
[F(2,36) ¼ 33.6; P < 0.001] was found. Post hoc t-tests showed that
40mg Ritalin successfully increased plasma MPH and Ritalinic
Acid.
Analysis of the Bond and Lader Alert subscale showed a
main effect of Treatment [F(1,18) ¼ 10.2; P < 0.01]. Participants
reported to be more alert in the MPH than in the placebo ses-
sion. No other effects were found.
Performance
Response speed analysis confirms that MPH increases response
vigor. Repeated measures ANOVA on the reaction times (n ¼ 19)
showed a main effect of Treatment [F(1,17) ¼ 4.9; P ¼ 0.04]. MPH
reduced the average RT across FB types from on average 603 (SE
¼ 24) ms in the placebo session to 598 (SE ¼ 46) ms in the MPH
session. Although the reaction time values did not show evi-
dence of a significant interaction between feedback type and
drug condition [F(1,17) ¼ 0.213, P ¼ 0.650], the evidence for
increased vigor was more clear when looking at the bulk of the
more neutral feedback trials (gain 5/7/25/27 or loss 5/7/25/27). In
these gain trails RT dropped from 615 in placebo to 595ms under
MPH, and in these loss trials it dropped from 583 to 570ms, re-
spectively (see Figure 2). In line with Camara et al. (2010), overall
participants chose the 25 more often (in 58%, SD ¼ 14) than the 5
(42%, SD ¼ 14) [T(18) ¼ 2.4; P ¼ 0.03]. However, there was no sig-
nificant difference in the RT for choosing the 25 points option
compared with the five points option [F(1,17) ¼ 0.6, P ¼ 0.461]. No
effects of MPH on choice behavior were found.
Task-related brain activation during placebo
During placebo, the relative RPE sizes correlated positively with
the BOLD signal in the ventral striatum during feedback delivery
(model 1; Tpeak voxel ¼ 7.68, PFWE-corrected ¼ 0.000) and also
during choice of the next trial (model 3; Tpeak voxel¼ 7.01,
PFWE-corrected ¼ 0.000) (see Table 1 and Figure 3 for striatal ac-
tivations and Supplementary Table S1 for a complete overview
of task-related brain activity). The latter finding confirms the
hypothesis that reward history adjusts current reward expect-
ation. In contrast, the salience of the RPE (i.e. regardless of its
valence; model 2) did not modulate striatal activity (Table 1).
Effects of MPH on task-related brain activation
This relationship between the relative size of RPEs and the rela-
tive size of the event-related BOLD response was not altered by
MPH as there was no significant MPH-related difference in the
amount of modulation of the BOLD response estimated in ei-
ther of the models (models 1–3). MPH did however change the
absolute size of the phasic striatal BOLD response related to
feedback (model 4). A whole brain analysis of the pooled re-
sponse to all feedback types under MPH compared with placebo
(model 4) revealed that MPH reduced the BOLD response
Table 1. Task-related BOLD responses in the striatum in the placebo session, based on whole brain analysis (for a complete list of the results of
this whole brain analysis see Supplementary Table S1)
Regions BA PFWE-corrected
at cluster level
Peak Coordinates x, y, z Peak T-value Cluster size
A. Feedback-related BOLD responses that correlate positively with the size of the RPE
Ventral striatum 0.000 19, 4, 13 7.68 1380
11, 10, 5 7.23
9, 8, 7 6.89
B. Feedback-related BOLD responses that correlate positively with the size of the salience of feedback (absolute value of the RPE)
No significant striatal cluster was found
C. Choice-related BOLD response that correlates positively with RPE history.
Ventral striatum 0.000 11, 6, 5 7.01 1838
7, 10, 5 6.77
1, 4, 9 5.85
Regions BA PFWE-corrected
at cluster level
Peak Coordinates x, y, z Peak T-value Cluster size
D. Regions in which MPH reduced the BOLD response during feedback (across feedback types)
Ventral striatum 0.000 19, 6, 17 4.70 131
23, 12, 3 4.70
23, 16, 9 4.35
Ventral striatum 0.012 25, 12, 7 4.61 70
21, 20, 11 3.43
21, 10, 15 3.43
Effects of MPH on the BOLD response during feedback (across feedback types). Local maxima more than 8.0mm apart are shown.
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bilateral in the ventral striatum (left ventral striatum: Tpeak
voxel ¼ 4.70, PFWE-corrected ¼ 0.000; right ventral striatum:
Tpeak voxel ¼ 7.61, PFWE-corrected ¼ 0.000; see Table 1 and
Figures 4A and C).
Together with the finding that MPH does not change the na-
ture of the relationship between BOLD response and RPE, this
result suggests that the tonic increase in dopamine induced by
MPH leads to a downward shift of the entire RPE-response curve
by on average 0.17% signal change.
To confirm that MPH did not change the relationship be-
tween our parametric manipulations of RPEs and the event-
related BOLD response, a follow-up slope analysis was carried
out on the extracted ROI-based data. This linear regression ana-
lysis showed that the linear trend in the BOLD amplitudes over
RPE categories, as opposed to amplitudes, was not significantly
changed by drug condition (t ¼ 0.96; P ¼ 0.34).
Finally, we verified the influence of tonic dopamine on re-
ward expectancy by comparing the percentage signal change
between the two drug conditions at the time of the choice (esti-
mated in model 4). As the choice for a reward level brings about
a certain reward expectation, reflected in the striatal BOLD-
response towards the choice cue, tonic dopamine increase
through MPH should increase this average reward expectation
signal. The ROI-based data extracted from the ventral striatum
confirmed this (t ¼ 1.93; P ¼ 0.04; Figure 4B).
No effects of MPH were found on the negative likelihood
(F(1,18) ¼ 0.2; P > 0.1), the learning rate [F(1,18) ¼ 1.47; P > 0.1),
and the exploration parameter [F(1,18) ¼ 0.0; P > 0.1]; output
parameters of the reinforcement learning model.
Discussion
The results presented here are in line with the predictions of
Niv (2007). Not only was high tonic dopamine associated with
increased response readiness, but it also enhanced the BOLD
signal in the ventral striatum associated with reward expect-
ation, i.e. at the time when participants chose for a particular
reward level. This was evident when comparing drug condi-
tions, but also on a trial by trial basis, as the amplitude of this
BOLD response was systematically higher (or lower) depending
on the size of the RPE in the previous trial. This confirms that
the tonic dopamine level constitutes an average reward expect-
ation signal.
Our results also provide direct support for the hypothesis of
Cools et al. (2011) that the striatal tonic dopamine level affects
the impact of the phasic RPE-related dopamine response. We
observed that the tonic increase in dopamine induced by MPH,
in contrast to the upward sizing of the BOLD signal at the time
of choice, leads to a downward shift of the phasic BOLD re-
sponse in the ventral striatum at the time of feedback. At the
Fig. 4. The average percentage signal change (n¼20) with SEM across the two ventral striatal clusters (A) (coronal slices at x¼15) for Choice (B) and for the different
types of feedback (C) during the placebo and MPH session (model 4).
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same time, the RPE-related modulation of the response is left
intact. As there was no interaction of any kind between the
drug conditions and the RPE size in the BOLD signal, we con-
clude that the tonic and phasic BOLD effects of our dopamine
manipulation are additive, as if the tonic dopamine effect repre-
sents a constant value subtracted from the phasic BOLD re-
sponse. This strongly suggests that these two phenomena arise
from independent mechanisms.
It is not yet known what these mechanisms are. A tempting
explanation is that these BOLD modulations result from a drug
induced metabolic change. It has been demonstrated with glu-
cose PET in humans that MPH lowers metabolic activity in the
striatum (Wang et al., 1994; Volkow et al., 2008, 2013). A global,
MPH-induced reduction in BOLD activation, independent
of reward-related BOLD activity following phasic dopamine
delivered in the striatum (Jonasson et al., 2014), would very well
account for the results reported here. However, because the
MPH-induced dopamine enhancement is tonic, the metabolic
change it induces is tonic. Hence, it served as the baseline BOLD
signal against which relative changes in phasic dopamine are
contrasted during both placebo and MPH. The metabolic effect
of MPH therefore remains invisible to BOLD-fMRI.
Consequently, the global downward shift of the phasic BOLD re-
sponse amplitude that we observed, can only emerge through a
direct influence of the enhanced tonic dopamine level on the
manifestation of the phasic dopamine response in the BOLD
signal.
Three established mechanisms could explain the reduction
of phasic dopamine due to an increase in tonic dopamine. First,
a higher tonic dopamine level increases stimulation of pre-
synaptic dopamine autoreceptors, which diminishes phasic
dopamine release (Beaulieu and Gainetdinov, 2011). Second,
increased tonic dopamine induces postsynaptic dopamine re-
ceptor desensitization, resulting in a reduced postsynaptic re-
sponse to phasic dopamine (Jonasson et al., 2014). A third
possibility relates to the suggested functional specificity of the
striatal compartments. The striosome subsystem is the primary
target of reward-related signals and provides inhibitory regula-
tory feedback to midbrain dopamine neurons (Canales, 2005).
We hypothesize that the MPH-induced increase in average re-
ward expectancy increases activity in striosome output neuro-
ns—detected as increased BOLD signal following the choice
cue—which then down-regulate midbrain dopamine neurons,
resulting in a reduced phasic dopamine response in the
striatum.
An important implication of our results is that MPH could be
used to down regulate the phasic reward response. In cocaine
addicts, e.g. drug-related cues are associated with a phasic re-
ward response in the ventral striatum (Stuber et al., 2005; Philips
et al., 2013). Our results suggest that MPH could be used to sup-
press this response and reduce relapse rate. Furthermore, previ-
ous studies have shown abnormal reward sensitivity in ADHD
(Furukawa et al., 2014) which can be normalized by MPH
(Mizuno et al., 2013). Our findings suggest that MPH normalizes
reward sensitivity by reducing the phasic dopamine response to
immediate reward predicting cues. As a last example, individual
differences in striatal reward responsiveness to food and sexual
images have been shown to predict subsequent weight gain and
sexual activity (Demos et al., 2012). Normalization of this height-
ened sensitivity to food or sex related cues might increase the
success rate of behavioral control treatment schemes for indul-
gence in overeating and sexual activity.
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Supplementary data are available at SCAN online.
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